PARADISE Trademark

Trademark Overview


On Monday, May 5, 2025, a trademark application was filed for PARADISE with the United States Patent and Trademark Office. The USPTO has given the PARADISE trademark a serial number of 99170052. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, November 21, 2025. This trademark is owned by ReCor Medical, Inc.. The PARADISE trademark is filed in the Medical Instrument Products category with the following description:

Medical device systems consisting of medical devices for treating heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical devices for treating heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical apparatus and instruments for treating heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Energy-emitting catheter-based systems consisting of medical devices for use in treating a variety of medical conditions, including heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance, among other medical conditions, and also c...
paradise

General Information


Serial Number99170052
Word MarkPARADISE
Filing DateMonday, May 5, 2025
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, November 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical device systems consisting of medical devices for treating heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical devices for treating heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical apparatus and instruments for treating heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Energy-emitting catheter-based systems consisting of medical devices for use in treating a variety of medical conditions, including heart failure, chronic kidney disease, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance, among other medical conditions, and also consisting of plastic containers for medical fluids, carts, and remote controls for medical devices

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, May 5, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReCor Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303

Trademark Events


Event DateEvent Description
Monday, May 5, 2025NEW APPLICATION ENTERED
Monday, May 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 5, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 22, 2025ASSIGNED TO EXAMINER
Tuesday, September 23, 2025NON-FINAL ACTION WRITTEN
Tuesday, September 23, 2025NON-FINAL ACTION E-MAILED
Tuesday, September 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 21, 2025FINAL REFUSAL WRITTEN
Friday, November 21, 2025FINAL REFUSAL E-MAILED
Friday, November 21, 2025NOTIFICATION OF FINAL REFUSAL EMAILED